
    
      Methodology: Prospective, non blinded, open label, single center phase II study

      Criteria for evaluation: Assessment of response will be assessed radiologically according to
      RECIST criteria after completion of the two cycles. Evaluation will be by physical
      examination, chest X-ray, abdomen-pelvis CT scan Safety criteria: Physical examination, vital
      signs, performance status, CBC, serum chemistry, NCI CTC V.3.0
    
  